Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Willekens

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Infection|December 3, 2016
Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patientDaniela Gavril, Paul-Louis Woerther, Aicha Ben Lakhdar, et al.
Leukemia Research|March 5, 2015
Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failureStéphanie Harel, Amina Cherait, Céline Berthon, et al.
Blood Advances|January 4, 2018
Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokinesYanyan Zhang, Liang He, Dorothée Selimoglu-Buet, et al.
Bulletin Du Cancer|October 9, 2025
Therapy related myeloid neoplasm, same but different?Lina El Murr, Khalil Saleh, Florence Pasquier, et al.
Neurosurgery|April 9, 2015
An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case ReportBadih Daou, Marc Zanello, Pascale Varlet, et al.
American Journal of Hematology|March 12, 2014
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNANicolas Duployez, Olivier Nibourel, Alice Marceau-Renaut, et al.
European Journal of Haematology|December 1, 2011
Prognostic value of PINI index in patients with multiple myelomaSophie Dupire, Mathieu Wemeau, Houria Debarri, et al.
European Journal of Haematology|January 29, 2021
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapyPamela Abdayem, Nathalie Ibrahim, Yolla El Dakdouki, et al.
Blood|August 22, 2014
JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiationRodolphe Besancenot, Damien Roos-Weil, Carole Tonetti, et al.
European Journal of Haematology|December 16, 2019
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II resultJean-Marie Michot, Maxime Annereau, Alina Danu, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Infection|December 3, 2016
Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patientDaniela Gavril, Paul-Louis Woerther, Aicha Ben Lakhdar, et al.
Leukemia Research|March 5, 2015
Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failureStéphanie Harel, Amina Cherait, Céline Berthon, et al.
Blood Advances|January 4, 2018
Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokinesYanyan Zhang, Liang He, Dorothée Selimoglu-Buet, et al.
Bulletin Du Cancer|October 9, 2025
Therapy related myeloid neoplasm, same but different?Lina El Murr, Khalil Saleh, Florence Pasquier, et al.
Neurosurgery|April 9, 2015
An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case ReportBadih Daou, Marc Zanello, Pascale Varlet, et al.
American Journal of Hematology|March 12, 2014
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNANicolas Duployez, Olivier Nibourel, Alice Marceau-Renaut, et al.
European Journal of Haematology|December 1, 2011
Prognostic value of PINI index in patients with multiple myelomaSophie Dupire, Mathieu Wemeau, Houria Debarri, et al.
European Journal of Haematology|January 29, 2021
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapyPamela Abdayem, Nathalie Ibrahim, Yolla El Dakdouki, et al.
Blood|August 22, 2014
JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiationRodolphe Besancenot, Damien Roos-Weil, Carole Tonetti, et al.
European Journal of Haematology|December 16, 2019
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II resultJean-Marie Michot, Maxime Annereau, Alina Danu, et al.
Pageof 5